GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,917 | -22.7% | 20,395 | 0.0% | 0.00% | – |
| Q2 2023 | $6,363 | -49.5% | 20,395 | -10.9% | 0.00% | – |
| Q1 2023 | $12,592 | -33.6% | 22,895 | +7.0% | 0.00% | -100.0% |
| Q4 2022 | $18,950 | -50.1% | 21,395 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $38,000 | -40.6% | 21,395 | -0.0% | 0.00% | -50.0% |
| Q2 2022 | $64,000 | +3.2% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $62,000 | – | 21,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
| Welch Group, LLC | 10,000 | $67,000 | 0.01% |
| Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
| ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
| TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
| Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |